|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.12 CNY | -0.90% |
|
-5.56% | -1.28% |
| 06-11 | China Approves ApicHope Subsidiary's Clinical Trials for Leukemia Drug | MT |
| 05-22 | ApicHope Pharmaceutical Unit Gets China Nod for Hemostatic Drug | MT |
| Market Cap | 14.86B 2.19B 1.92B 1.77B 1.65B 3.11B 207B 3.13B 21.06B 8.2B 102B 8.23B 8.06B 354B | P/E 2024 |
-14.3x | P/E 2025 | -44.9x |
|---|---|---|---|---|---|
| Enterprise Value | 16.41B 2.42B 2.12B 1.96B 1.83B 3.43B 229B 3.46B 23.27B 9.06B 113B 9.1B 8.9B 391B | EV / Sales 2024 |
6.12x | EV / Sales 2025 | 17.8x |
| Free-Float |
31.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.90% | ||
| 1 week | -5.56% | ||
| Current month | -24.57% | ||
| 1 month | -16.78% | ||
| 3 months | +5.78% | ||
| 6 months | -6.97% | ||
| Current year | -1.28% |
| 1 week | 31.37 |  | 35.18 |
| 1 month | 31.37 | | 45.78 |
| Current year | 29.31 | | 45.88 |
| 1 year | 29.31 | | 81.48 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 2015-11-10 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 2015-11-10 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 2020-12-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ke Jian Zhang
BRD | Director/Board Member | 70 | 2024-06-30 |
Han Xiong Li
CHM | Chairman | 52 | 2015-11-10 |
Han Dong Li
BRD | Director/Board Member | 58 | 2015-11-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-04 | Buy | Director | 4,200 | 0.0010% | ||
| 11-23 | Buy | Director | 7,000 | 0.0017% | ||
| 23-08-31 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | -5.56% | -32.19% | +20.66% | 2.21B | |
| +1.34% | +3.05% | +11.88% | +87.81% | 46.74B | |
| +0.90% | +4.02% | +51.42% | +90.96% | 34.33B | |
| +4.73% | +1.89% | -5.60% | +40.32% | 11.57B | |
| +1.37% | -1.74% | +13.42% | +93.80% | 11.42B | |
| -0.95% | +0.96% | +37.43% | +127.27% | 9.09B | |
| +1.11% | -2.15% | +16.27% | +41.36% | 6.98B | |
| -0.98% | +0.83% | +33.92% | +240.86% | 6.62B | |
| +4.29% | +6.01% | +50.84% | -15.23% | 6.55B | |
| +1.32% | -1.66% | -34.40% | -0.52% | 5B | |
| Average | +1.22% | -0.61% | +14.30% | +72.73% | 14.05B | |
| Weighted average by Cap. | +1.35% | +0.83% | +22.61% | +83.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.45B 214M 187M 173M 162M 303M 20.23B 305M 2.06B 800M 9.95B 804M 786M 34.56B | 932M 138M 120M 111M 104M 195M 13.01B 196M 1.32B 514M 6.39B 517M 506M 22.22B |
| Net income | -540M -79.73M -69.67M -64.44M -60.15M -113M -7.53B -114M -766M -298M -3.7B -299M -293M -12.87B | -338M -49.87M -43.58M -40.31M -37.62M -70.63M -4.71B -71.14M -479M -186M -2.32B -187M -183M -8.05B |
| Net Debt | 1.22B 180M 157M 145M 136M 254M 16.98B 256M 1.73B 672M 8.35B 675M 660M 29B | 1.56B 230M 201M 186M 173M 326M 21.73B 328M 2.21B 859M 10.68B 863M 845M 37.12B |
Employees
1,294
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-21 | 33.12 ¥ | -0.90% | 11,972,440 |
| 26-06-18 | 33.42 ¥ | +1.95% | 10,027,960 |
| 26-06-17 | 32.78 ¥ | -1.27% | 7,395,594 |
| 26-06-16 | 33.20 ¥ | -5.87% | 14,481,520 |
| 26-06-15 | 35.27 ¥ | +0.57% | 8,213,306 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
